Vmn2r77 Inhibitors
Vmn2r77 include a range of compounds that interact with various signaling pathways and receptors that are integral for the protein's function. Diphenhydramine competes with histamine at H1 receptor sites, which are necessary for Vmn2r77 activation or signaling, leading to its inhibition. Similarly, Methoctramine blocks muscarinic acetylcholine receptors, possibly involved in the signaling pathway of Vmn2r77, which results in its functional inhibition. Losartan serves as an angiotensin II receptor antagonist, and by blocking the AT1 receptor, it could inhibit the potential roles Vmn2r77 plays in blood pressure regulation. Propranolol, by antagonizing beta-adrenoceptors, can inhibit Vmn2r77 by disrupting the upstream or parallel pathways necessary for its activation and function. Yohimbine, through its antagonistic effect on alpha-2 adrenergic receptors, can inhibit Vmn2r77 by regulating neurotransmitter release required for Vmn2r77 activity.
Ondansetron, as a serotonin 5-HT3 receptor antagonist, prevents serotonin action, which can have a regulatory role on Vmn2r77's signaling cascade, leading to inhibition. Nifedipine and Diltiazem, both calcium channel blockers, can inhibit Vmn2r77 by impeding calcium influx essential for Vmn2r77's signaling pathways. Atropine, another muscarinic antagonist, can inhibit Vmn2r77 by modulating the pathways in which Vmn2r77 is involved. Tetrodotoxin, by blocking sodium channels crucial for action potential generation, can inhibit signaling necessary for Vmn2r77-mediated processes. Lastly, Mifepristone can inhibit Vmn2r77 by antagonizing the glucocorticoid receptor, impacting the signaling pathways Vmn2r77 is known to participate in, resulting in the inhibition of this protein's function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $51.00 $131.00 | ||
Lidocaine, a sodium channel blocker, can inhibit Vmn2r77 by stabilizing the neuronal membrane and thereby inhibiting the initiation and conduction of nerve impulses that could be necessary for Vmn2r77 function. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Losartan, an angiotensin II receptor antagonist, can inhibit Vmn2r77 by blocking the AT1 receptor which may interact with Vmn2r77's pathway, thus inhibiting its potential functional role in blood pressure regulation. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol, a beta-adrenergic antagonist, can inhibit Vmn2r77 by blocking beta-adrenoceptors which may be upstream or parallel signaling pathways required for Vmn2r77 activation and function. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
Yohimbine, an alpha-2 adrenergic receptor antagonist, can inhibit Vmn2r77 by blocking alpha-2 receptors which could regulate the release of neurotransmitters that are necessary for Vmn2r77's activity. | ||||||
Ondansetron | 99614-02-5 | sc-201127 sc-201127A | 10 mg 50 mg | $82.00 $333.00 | 1 | |
Ondansetron, a serotonin 5-HT3 receptor antagonist, can inhibit Vmn2r77 by preventing serotonin action, which may have a regulatory role on Vmn2r77's signaling cascade, leading to its functional inhibition. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine, a calcium channel blocker, can inhibit Vmn2r77 by impeding calcium influx, which is crucial for various signaling pathways and could be necessary for Vmn2r77's proper function. | ||||||
Atropine | 51-55-8 | sc-252392 | 5 g | $204.00 | 2 | |
Atropine, a muscarinic antagonist, can inhibit Vmn2r77 by blocking muscarinic acetylcholine receptors which could have a role in modulating the pathways Vmn2r77 is involved in, resulting in functional inhibition. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Diltiazem, a calcium channel blocker, can inhibit Vmn2r77 by limiting calcium entry, which is important for the regulation of various signaling pathways that may be essential for Vmn2r77's activity. | ||||||
Mifepristone | 84371-65-3 | sc-203134 | 100 mg | $61.00 | 17 | |
Mifepristone, a glucocorticoid receptor antagonist, can inhibit Vmn2r77 by blocking the glucocorticoid receptor, which may have downstream effects on the signaling pathways that Vmn2r77 engages in, resulting in functional inhibition. | ||||||